Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study - Panitch, Hillel; Miller, Aaron; Paty, Donald; Weinshenker, Brian (Neurology, 2004)
Keywords: Brain - pathology; Contrast Media; Depression; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Gadolinium; Humans; Immunologic Factors - administration & dosage; Immunologic Factors - adverse effects; Immunologic Factors - immunology; Immunologic Factors - therapeutic use; Injections, Subcutaneous; Interferon beta-1b; Interferon-beta - administration & dosage; Interferon-beta - adverse effects; Interferon-beta - immunology; Interferon-beta - therapeutic use; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive - drug therapy; Multiple Sclerosis, Chronic Progressive - pathology; Multiple Sclerosis, Chronic Progressive - psychology; Neutralization Tests; Outcome Assessment (Health Care); Quality of Life; Severity of Illness Index